Beta Bionics, Inc. (NASDAQ: BBNX) reported Q2 EPS of ($0.39), $0.03 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $23.2 million.

For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.